AstraZeneca Pharma's Q4 FY25 results :

- Net Profit: ₹58.25 crore, up 48% year-over-year - Revenue: ₹480.48 crore, a 25.3% increase from the same period last year - Full-Year Revenue Growth: 32% rise compared to the previous year, driven by strong performance across therapeutic segments